论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
用于直接清除或中和脂多糖的纳米药物递送系统
Authors Chen L , Pan R , Xu X , Guo J
Received 4 December 2024
Accepted for publication 28 April 2025
Published 3 July 2025 Volume 2025:20 Pages 8653—8673
DOI https://doi.org/10.2147/IJN.S510037
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Krishna Nune
Lu Chen,1 Ran Pan,1 Xiaoling Xu,2 Junping Guo1
1Rehabilitation and Nursing School, Hangzhou Vocational & Technical College, Hangzhou, Zhejiang, People’s Republic of China; 2Shulan International Medical College, Zhejiang Shuren University, Hangzhou, Zhejiang, People’s Republic of China
Correspondence: Xiaoling Xu, Shulan International Medical College, Zhejiang ShurenUniversity, Hangzhou, 310015, People’s Republic of China, Tel/Fax +86-571-88208435, Email ziyao1988@zju.edu.cn Junping Guo, Rehabilitation and Nursing School, Hangzhou Vocational & Technical College, Hangzhou, Zhejiang, 310018, People’s Republic of China, Tel/Fax +86-571-56700217, Email guojunping@hzvtc.edu.cn
Abstract: Lipopolysaccharide (LPS) is a unique component of the outer wall of gram-negative bacteria and is a complex composed of lipids and polysaccharides. Normally, liver sinusoidal endothelial cells (LSECs) systemically clear LPS via unknown mechanisms. However, under pathological conditions, LPS causes lethal endotoxemia if it cannot be rapidly cleared from the blood circulation. Currently, an increasing number of drugs have demonstrated the ability to clear or neutralize LPS. However, due to their inherent characteristics, such as low biocompatibility and short half-life, their clinical applications are limited. Nanodrug delivery systems have the advantages of improving pharmacokinetics, increasing bioavailability, reducing the occurrence of side effects, and prolonging drug circulation time, which can compensate for the shortcomings of traditional drugs. This review summarizes nanodrug delivery systems that can clear or neutralize LPS, such as polymer nanodrug delivery systems, lipid-based nanodrug delivery systems, peptide-based nanodrug delivery systems, inorganic nanodrug delivery systems, nanosponges, and extracellular vesicles, which provides an outlook on the application and future prospects of nanodrug delivery systems for clearing and neutralizing LPS.
Keywords: nanodrug delivery system, LPS clearance, LPS neutralization, inflammation, nanomaterial